Health professionals, in application of the first paragraph of II of Article L. 5131-5:
1° Must report without delay to the Agence nationale de sécurité du médicament et des produits de santé any serious adverse reactions of which they are aware ;
2° May report to the aforementioned agency any other adverse reactions of which they are aware and any reactions likely to result from misuse of the product.